The Impacts of the Different Anesthesia Methods on Patients of Transbronchial Cryobiopsy

Sponsor
Guangzhou Institute of Respiratory Disease (Other)
Overall Status
Unknown status
CT.gov ID
NCT04099069
Collaborator
(none)
60
1
2
8
7.5

Study Details

Study Description

Brief Summary

to evaluate the difference between the tracheal intubation (TI) and rigid bronchoscopy (RB) under general anesthesia on patients with transbronchial cryobiopsy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: anesthesia
N/A

Detailed Description

To evaluate the difference between the tracheal intubation (TI) and rigid bronchoscopy (RB) under general anesthesia on patients with transbronchial cryobiopsy. Comparing the difference between two groups in the operating duration, extubation duration, total anesthesia time, heart rate, blood pressure and arterial blood gas analysis. This is a prospective, randomized, controlled trial.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Impacts of the Different Anesthesia Methods on Patients of Transbronchial Cryobiopsy:A Prospective, Randomized, Controlled Trial
Anticipated Study Start Date :
Oct 1, 2019
Anticipated Primary Completion Date :
Jun 1, 2020
Anticipated Study Completion Date :
Jun 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: trachial intubation

patient was insert trachial intubation with normal frequency jet ventilation

Procedure: anesthesia
patient was insert trachial intubation or rigid bronchoscopy with ventilation under general anesthesia
Other Names:
  • insert rigid bronchoscopy under general anesthesia
  • Experimental: rigid bronchoscopy

    patient was insert trachial intubation with high frequency jet ventilation

    Procedure: anesthesia
    patient was insert trachial intubation or rigid bronchoscopy with ventilation under general anesthesia
    Other Names:
  • insert rigid bronchoscopy under general anesthesia
  • Outcome Measures

    Primary Outcome Measures

    1. the fluctuation of heart rate [24 hours]

      fluctuation of heart rate during the procedure

    2. the fluctuation of blood pressure [24 hours]

      the fluctuation of blood pressure during the procedure

    3. the fluctuation of arterial partial pressure of carbon dioxide [24 hours]

      the fluctuation of arterial partial pressure of carbon dioxide during the procedure

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. The patients are admitted in the institution as ILD, while undefined after thorough history collection, laboratory examination and radiological data.

    2. Transbronchial cryobiopsy(TBCB) is indicated by clinicians for definitive diagnosis and patients are content with the examination with agreement signed.

    3. Blood gas analysis, routine blood test, ECG examination, coagulation function, immunological examination, chest HRCT, and liver/kidney function test have been completed

    Exclusion Criteria:
    1. The radiological data indicates non-ILD

    2. The clinical examinations mentioned above are not completed.

    3. The patient cannot endure or does not agree the procedure.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The first affilliated hospital of Guanghzhou Medical university Guangzhou 广东 China 510120

    Sponsors and Collaborators

    • Guangzhou Institute of Respiratory Disease

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    ShiYue Li, Director of the Respiratory department, Guangzhou Institute of Respiratory Disease
    ClinicalTrials.gov Identifier:
    NCT04099069
    Other Study ID Numbers:
    • TS20180110
    First Posted:
    Sep 23, 2019
    Last Update Posted:
    Sep 23, 2019
    Last Verified:
    Sep 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by ShiYue Li, Director of the Respiratory department, Guangzhou Institute of Respiratory Disease
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 23, 2019